AvodahMed

The model is the entire product and the company exists to build it. AvodahMed is the digital health division of an AI company whose sibling division builds language translation technology, which is an unusually direct explanation for a multilingual capability that most scribes assert without provenance. This is the counterpart to the C graded on Veradigm Ambient Scribe: same intelligence, but here it belongs to the vendor rather than being licensed in.

Not assessed for the direct product. Oversight behaviour is documented for the Veradigm deployment, where codes arrive as suggestions for provider review, but this index does not transfer a claim from an integration partner's materials onto the vendor's own record. Ask what the review gate looks like when the product is bought direct rather than inside an EHR.

No accuracy figure, no model card, no named models, no evaluation methodology. Specialty aware documentation is claimed but neither enumerated nor substantiated. The disclosure asymmetry is worth noting on its own: more is publicly documented about how this model performs by its distribution partner than by the company that built it.

Better than pure self report, still short of evidence. The most useful figure is partner reported rather than vendor reported: Veradigm's vice president of technology stated that structured pilots run in September and October 2024 saved an average of seven to ten minutes per encounter, which is a specific operational number from the party doing the integrating. Against that, AvodahMed's own site carries a customer claim of chart closure rates up by nearly 70 percent with no denominator, and one testimonial appears under both brands with only the product name changed, the same six months of consistent use quote running as AvodahMed on one site and as Veradigm Ambient Scribe in partner coverage. Recycled attribution is not evidence of anything except shared marketing. No study, no controlled comparison, no independent evaluation.

Not assessed, and this is the highest value gap in the record. Veradigm describes the integrated product as producing real time transcripts without generating audio recordings, which would be a significant privacy architecture, but the claim was made by the distributor about its own deployment and has not been confirmed as a property of the AvodahMed engine itself. Establish directly whether audio is created, how long transcripts persist, and whether customer data trains the model.

Describes itself directly as a HIPAA compliant ambient scribe on its own materials. Specific business associate agreement terms are not published for inspection before contracting.

Not assessed. No named or dated attestation and no trust centre located in this pass.

Not a regulated medical device and no clearance is claimed or required for ambient documentation.

Nothing located. No fairness statement, no subgroup analysis, no accent or dialect performance disclosure. The absence is more striking here than elsewhere because the parent company's other division builds language translation technology, so the organisation plainly has the expertise to characterise cross language performance and has published none of it.

Two documented routes with real depth rather than a long list of shallow ones. It is listed on the athenahealth Marketplace, and it holds the deepest possible position inside Veradigm, which selected it specifically for integration depth over lightly integrated alternatives and certified it through the Veradigm Connect programme. That is a meaningful third party judgement about integration quality, made by a party with its own EHR to protect.

Not assessed. No hosting, residency or sub processor detail located in this pass.

No published rate card located for the direct product. Pricing runs through a demo request, and the embedded route is priced inside a Veradigm EHR contract, so neither path exposes a comparable number.

Ambulatory, with specialty aware documentation claimed but no specialty count, no note type list and no published set of supported capture languages. Coverage cannot be compared against competitors in this category that enumerate both.